Ionis (IONS) enjoys a diverse revenue stream, including numerous sources of collaborative and R&D revenues. These funds enable it to invest in the...
Vous n'êtes pas connecté
DelveInsight, “Hypertension Pipeline Insight 2024” report provides comprehensive insights about 100+ Hypertension companies and 100+ pipeline drugs in Hypertension pipeline landscape. It covers the Hypertension pipeline drug profiles, including clinical
Ionis (IONS) enjoys a diverse revenue stream, including numerous sources of collaborative and R&D revenues. These funds enable it to invest in the...
Scale Biosciences (Scale Bio), a leader in innovative and scalable single cell analysis solutions, today announced the launch of the “100 Million...
Adenoid Cystic Carcinoma Market According to DelveInsight, the dynamics of the Adenoid Cystic Carcinoma market are expected to evolve in the coming...
The exports of drugs and pharmaceuticals from India are experiencing consistent growth, reflecting an increase of 8.36 percent to reach (Dollor)...
Positive Phase 2a Fibromyalgia Results Deliver Pain Reduction in 100% of Patients, Strengthening IP Position and Clinical Trial Strategy Tryptamine...
Vimgreen Pharmaceuticals, a science─driven pharmaceutical company focused on the modulation of adenosine signalling, announced the completion of...
Updated Date: Fri, 09 Aug 2024 00:00:00 EDT
Updated Date: Thu, 15 Aug 2024 00:00:00 EDT